Pfizer-BioNTech report high efficacy of COVID boosters in study | Coronavirus pandemic News

The companies say phase III trial data show booster shot of COVID-19 vaccine was 95.6 percent effective against the disease.

American pharmaceutical company Pfizer and its partner BioNTech have said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the coronavirus, including the Delta…

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

‘You Don’t Get the Vaccine for Yourself’

Buhari presides over security meeting in Aso Rock